Adma Biologics (ADMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -38,773 | -25,008 | -71,648 | -54,998 | -37,285 |
| Depreciation Amortization | 4,170 | 2,139 | 7,250 | 5,265 | 3,392 |
| Accounts receivable | 9,693 | 2,947 | -15,340 | -7,155 | -10,307 |
| Accounts payable and accrued liabilities | -1,041 | 1,686 | 1,356 | 6,209 | -4,906 |
| Other Working Capital | -14,792 | -11,458 | -51,680 | -31,526 | -33,263 |
| Other Operating Activity | 1,899 | 3,680 | 17,693 | 3,302 | 16,878 |
| Operating Cash Flow | $-38,844 | $-26,013 | $-112,369 | $-78,904 | $-65,491 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6,782 | -2,842 | -13,511 | -9,835 | -7,047 |
| Investing Cash Flow | $-6,782 | $-2,842 | $-13,511 | $-9,835 | $-7,047 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 151,750 | 151,750 | N/A | N/A | N/A |
| Debt Repayment | -102,018 | -102,009 | -34 | -26 | -17 |
| Common Stock Issued | N/A | N/A | 121,144 | 67,316 | 59,102 |
| Other Financing Activity | -2,780 | -2,470 | -62 | -62 | -59 |
| Financing Cash Flow | $46,952 | $47,271 | $121,048 | $67,229 | $59,026 |
| Beginning Cash Position | 51,089 | 51,089 | 55,921 | 55,921 | 55,921 |
| End Cash Position | 52,415 | 69,505 | 51,089 | 34,411 | 42,409 |
| Net Cash Flow | $1,326 | $18,416 | $-4,832 | $-21,511 | $-13,512 |
| Free Cash Flow | |||||
| Operating Cash Flow | -38,844 | -26,013 | -112,369 | -78,904 | -65,491 |
| Capital Expenditure | -6,782 | -2,842 | -13,511 | -9,835 | -7,047 |
| Free Cash Flow | -45,626 | -28,856 | -125,880 | -88,739 | -72,538 |